La Jolla, CA, United States of America

Aihua Song

This inventor holds 1 USPTO granted patent. Top assignee: Kyowa Hakko Kirin Co., Limited. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Aihua Song. Retrieved from https://idiyas.com/inventor/aihua-song

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Aihua Song: Innovator in Immunology

Introduction

Aihua Song is a notable inventor based in La Jolla, California. He has made significant contributions to the field of immunology, particularly through his innovative work on antibodies.

Latest Patents

Aihua Song holds a patent for Interleukin 10 receptor (IL-10R) antibodies. This invention relates to IL-10 Receptor alpha (IL-10Rα) antibodies and their subsequences. It includes human and humanized IL-10 Receptor alpha antibodies, as well as isolated and purified forms. The patent also covers compositions that include these antibodies and methods that utilize them. Notably, the invention outlines methods for treating pathogen infections and reactivations, as well as strategies for vaccinating or immunizing against such infections.

Career Highlights

Aihua Song is associated with Kyowa Hakko Kirin Co., Limited, where he continues to advance his research and development efforts. His work has the potential to impact therapeutic approaches in immunology significantly.

Collaborations

Some of Aihua Song's coworkers include Shinichiro Kato and Rachel Soloff Nugent, who contribute to the collaborative environment that fosters innovation.

Conclusion

Aihua Song's contributions to the field of immunology through his patent on IL-10R antibodies exemplify the importance of innovation in medical science. His work not only enhances our understanding of immune responses but also opens new avenues for treatment and prevention of infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…